The genetics of the amyloidoses

被引:120
作者
Buxbaum, JN [1 ]
Tagoe, CE
机构
[1] Scripps Res Inst, Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] New York Harbour Healthcare Syst, Dept Vet Affairs, Med & Res Serv, New York, NY 10010 USA
[3] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10010 USA
来源
ANNUAL REVIEW OF MEDICINE | 2000年 / 51卷
关键词
amyloidosis; transthyretin; Alzheimer's disease; familial Mediterranean fever; serum amyloid A;
D O I
10.1146/annurev.med.51.1.543
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The amyloidoses are diseases in which abnormalities in the secondary structure of precursor proteins result in decreased solubility under physiologic conditions, with subsequent organ compromise. A total of 18 proteins have been definitively identified as amyloid precursors associated with human disease. Mutations in the genes that encode some of these proteins produce autosomal dominant disease in mid to late adult life. Until recently, the late onset has obscured the familial nature of some of the disorders. This is especially true in the apparently sporadic disease-producing deposits found even later in life. Ln many instances, these deposits are derived from precursors encoded by wild-type genes (perhaps influenced by alleles that are polymorphic in the normal population); in other cases, they represent autosomal dominant disease with age-dependent penetrance, The genetic aspects of amyloid diseases produced by the deposition of four different proteins have been investigated in detail and provide insights into the particular diseases and amyloidogenesis in general.
引用
收藏
页码:543 / 569
页数:27
相关论文
共 137 条
[1]
Aksentijevich I, 1997, CELL, V90, P797
[2]
Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation [J].
Amarzguioui, M ;
Mucchiano, G ;
Häggqvist, B ;
Westermark, P ;
Kavlie, A ;
Sletten, K ;
Prydz, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) :534-539
[3]
Andersson R, 1976, Acta Med Scand Suppl, V590, P1
[5]
DIFFERENCES IN BETA-AMYLOID (BETA/A4) DEPOSITION IN HUMAN PATIENTS WITH DOWNS-SYNDROME AND SPORADIC ALZHEIMERS-DISEASE [J].
ARMSTRONG, RA .
NEUROSCIENCE LETTERS, 1994, 169 (1-2) :133-136
[6]
A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis [J].
Asl, KH ;
Liepnieks, JJ ;
Nakamura, M ;
Parker, F ;
Benson, MD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (02) :584-588
[7]
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1 [J].
Asl, LH ;
Liepnieks, JJ ;
Asl, KH ;
Uemichi, T ;
Moulin, G ;
Desjoyaux, E ;
Loire, R ;
Delpech, M ;
Grateau, G ;
Benson, MD .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :221-227
[8]
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [J].
Bales, KR ;
Verina, T ;
Dodel, RC ;
Du, YS ;
Altstiel, L ;
Bender, M ;
Hyslop, P ;
Johnstone, EM ;
Little, SP ;
Cummins, DJ ;
Piccardo, P ;
Ghetti, B ;
Paul, SM .
NATURE GENETICS, 1997, 17 (03) :263-264
[9]
Baumeister R, 1997, Genes Funct, V1, P149
[10]
THE LDL RECEPTOR RELATED PROTEIN, LRP, IS AN APOLIPOPROTEIN-E-BINDING PROTEIN [J].
BEISIEGEL, U ;
WEBER, W ;
IHRKE, G ;
HERZ, J ;
STANLEY, KK .
NATURE, 1989, 341 (6238) :162-164